Christopher Chapman

Associate Manufacturing Scientist at Cygnus Technologies - Boiling Spring Lakes, NC, US

Christopher Chapman's Contact Details
HQ
910-454-9442
Location
Chapel Hill,North Carolina,United States
Company
Cygnus Technologies
Christopher Chapman's Company Details
Cygnus Technologies logo, Cygnus Technologies contact details

Cygnus Technologies

Boiling Spring Lakes, NC, US • 50 - 99 Employees
BioTech/Drugs

Cygnus Technologies, part of Maravai LifeSciences, is the biopharmaceutical industry's partner in host cell protein (HCP) and other process-related impurity detection and analytics. In addition, Cygnus now provides innovative viral clearance solutions as well. Cygnus helps companies developing therapeutic proteins, vaccines, antibodies, plasma derivatives and gene therapies to ensure the safety of biotherapeutics prior to human trials, regulatory approval and commercial release. Cygnus provides analytical tools and solutions delivering insights to improve bioprocess development for faster regulatory approval and better clinical outcomes. Cygnus is an industry pioneer responsible for developing and commercializing the first generic assay kits for HCP detection. Its reputation for quality is recognized by the industry and global regulatory agencies. It continues to advance the science of bioprocess impurity detection with new breakthroughs, including its Antibody Affinity Extraction™ (AAE) technology and orthogonal methods of HCP analysis that integrate Mass Spectrometry, AAE and ELISA. To reduce the cost and risk associated with viral clearance studies, Cygnus also offers a unique approach that utilizes non-infectious mock virus particles through its MockV™ virus clearance kits. Cygnus' proprietary technology, available through its off-the-shelf and custom analytics programs, sets the gold standard for enabling HCP and other bioprocess impurity antibody assays. Cygnus delivers best-in-class customer service and technical expertise, operational excellence and ISO-9001:2015 certified quality management systems. Founded by Ken Hoffman in 1997, Cygnus continues to support and advance technology in order to improve biotherapeutic safety and accelerate the movement of new therapeutics through the development and regulatory approval process. Located in Southport, North Carolina, Cygnus Technologies is online at www.cygnustechnologies.com.

Host Cell Protein ELISA Kits Host Cell DNA Detection & Extraction Kits Process-Specific HCP Assay Development Antibody Affinity Extraction Host Cell DNA Detection & Extraction Kits Host Cell DNA Detection & Extraction Kits
Details about Cygnus Technologies
Frequently Asked Questions about Christopher Chapman
Christopher Chapman currently works for Cygnus Technologies, LLC.
Christopher Chapman's role at Cygnus Technologies, LLC is Associate Manufacturing Scientist.
Christopher Chapman's email address is ***@cygnustechnologies.com. To view Christopher Chapman's full email address, please signup to ConnectPlex.
Christopher Chapman works in the Research industry.
Christopher Chapman's colleagues at Cygnus Technologies are Christian Pierce, Erin Hoffman, Angelo Cui, Sara Brown, Mark Pliakos, Anne Porter, Stephen Stahlschmidt and others.
Christopher Chapman's phone number is 910-454-9442
See more information about Christopher Chapman